Success Stories: Research Associate in the Field of Neuroscience in Wisconsin Receives EB-1A Approval
Client’s Testimonial:
Thank you very much. I am very excited to hear this wonderful news and very happy about my decision that I only approached your firm. Your responses were very assuring from the beginning, Really appreciate everything and your excellent professional help. I will definitely recommend your firm to my friends.
On February 14, 2014, A Research Associate in the Field of Neuroscience in Wisconsin Received EB-1A (Alien of Extraordinary Ability) Approval (Approval Notice)
General Field: Neuroscience
Position at the Time of Case Filing: Research Associate
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Wisconsin
Approval Notice Date: February 14, 2014
Processing Time: 18 Days (with Premium Processing)
Case Summary:
North America Immigration Law Group – WeGreened.com represented a research associate in the field of neuroscience who had strived to understand how therapy can minimize stroke damage. In order to answer this question, the client researched a highly specialized, damaged area of the brain after cerebral strokes had occurred. Before filing this case, the client had contributed towards the identification of molecular targets in the cerebral ischemia, which has a key role in the development of screening approaches of antistroke agents. More recently, he had studied the role of non-coding RNA and miRNA in cerebral ischemia and reperfusion injury. The aforementioned research resulted in 1 book chapter, 14 scientific journal articles, and 12 presentations which had been cited a total of 643 times before filing this client’s case. In addition to his research and publications, this client had reviewed 11 articles. One independent recommender stated: “[Client] is a talented investigator from whose work and insight biomedicine is being enriched and new treatments for cerebral ischemia are being developed. The discoveries made by [Client’s] translational research have provided new avenues to prevent and stop brain damage form cerebral ischemia, and inform healthy mitochondrial function. In my judgment, [Client] has made major contributions to research on cerebral ischemia by establishing a base line for research and then superseding it with his findings that indicate suppression of mitochondrial dynamic imbalance reduces ischemic brain damage. This research is an example of how scientific advancement relies on fresh ideas from talented researchers, like [Client], who have a novel research perspective that allows them to excel at translational research.” This EB-1A (Alien of Extraordinary Ability) petition received approval 4 days after the USCIS received the Premium Processing request.

